Orexin-A

From WikiMD's WELLNESSPEDIA

Orexin-A‏‎ is a type of neuropeptide that plays a significant role in regulating sleep-wake cycles, appetite, and energy homeostasis. It is one of the two orexin peptides, the other being Orexin-B‏‎. Both are produced in the hypothalamus, a region of the brain that controls many bodily functions.

Structure and Function[edit]

Orexin-A‏‎ is a 33-amino acid peptide that is highly conserved across species. It is produced by the prepro-orexin gene, which also produces Orexin-B‏‎. The orexin system consists of these two peptides and two G-protein coupled receptors, OX1R and OX2R. Orexin-A‏‎ has equal affinity for both receptors, while Orexin-B‏‎ preferentially binds to OX2R.

Orexin-A‏‎ and Orexin-B‏‎ are primarily produced by neurons in the lateral hypothalamus. These neurons project widely throughout the brain, allowing the orexins to regulate a variety of functions. The orexins are particularly important for maintaining wakefulness; loss of orexin-producing neurons is a cause of the sleep disorder narcolepsy.

Role in Sleep-Wake Regulation[edit]

Orexin-A‏‎ plays a crucial role in the regulation of the sleep-wake cycle. It promotes wakefulness and inhibits REM sleep. In individuals with narcolepsy, a disorder characterized by excessive daytime sleepiness and cataplexy, there is a loss of orexin-producing neurons in the hypothalamus. This loss is thought to be the primary cause of the symptoms of narcolepsy.

Role in Appetite and Energy Homeostasis[edit]

In addition to its role in sleep regulation, Orexin-A‏‎ also regulates appetite and energy homeostasis. It stimulates food intake and increases energy expenditure, contributing to the regulation of body weight. Orexin-A‏‎'s role in energy homeostasis is thought to be mediated through its effects on the autonomic nervous system.

Clinical Significance[edit]

Given its role in sleep and energy homeostasis, Orexin-A‏‎ is a potential target for the treatment of disorders such as narcolepsy, insomnia, and obesity. Several drugs that target the orexin system are currently in development or in clinical trials.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.